Gland Pharma Limited (NSE:GLAND)
India
· Delayed Price · Currency is INR 1,526.60
+6.65 (0.44%)
Feb 21, 2025, 3:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 251.51 billion as of February 21, 2025. Its market cap has decreased by -25.29% in one year.
Market Cap
251.51B
Enterprise Value
226.58B
Revenue
57.29B
Ranking
n/a
PE Ratio
35.70
Stock Price
1,526.60
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 251.51B, a decrease of -15.35%. That is a compound annual growth rate of -3.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 251.51B | -14.20% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,005.21B |
| Divi's Laboratories | 1,587.05B |
| Cipla | 1,195.03B |
| Mankind Pharma | 968.92B |
| Apollo Hospitals Enterprise | 918.92B |
| Zydus Lifesciences | 905.26B |
| Aurobindo Pharma | 651.22B |
| Alkem Laboratories | 564.35B |